Navigation Links
Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology
Date:5/20/2010

SAN DIEGO, May 20 /PRNewswire/ -- Biocept, Inc. ("Biocept"), an emerging leader in rare cell capture, announced today that the U.S. Patent and Trademark Office has issued a patent for Biocept's cell separation technology using a microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell Separation and Analysis and Method of Using" protects Biocept's microflow device to isolate cells from a bodily fluid using a flow path where straight-line flow is interrupted by transverse posts arranged in a random pattern. Sequestering agents, such as antibodies, are used to immobilize the cells in the cavity of the device. Cells can then be analyzed inside the microchannel using morphological, immunohistochemical, or fluorescent in situ hybridization (FISH) tests, or the cells can be released from the channel for molecular analysis following extraction of DNA.

"This patent establishes Biocept's leadership position in using a microfluidic device to capture and analyze rare cells for prenatal or cancer applications," said Stephen M. Coutts, President and CEO of Biocept. "We are using this invention to develop innovative proprietary tests in which we capture and analyze circulating tumor cells from a blood sample from cancer patients. These circulating tumor cells provide genetic information about the patient's disease and can potentially guide the clinicians in making therapeutic choices to maximize patient response. We look forward to bringing this technology through to commercialization and making personalized medicine a reality for cancer patients and their families."

About Biocept

Biocept, whose focus is in cell separation technology, develops novel diagnostic assays for personalized medicine in detection and monitoring of recurrent cancer. Biocept's CEE™ Cell Enrichment and Extraction platform combines sophisticated attachment chemistry with mathematically modeled fluid dynamics to enable earlier, accurate and less invasive diagnoses. Isolation, purification and genetic analysis of rare cells, such as circulating tumor cells, are managed within our state-of-the-art CLIA-accredited laboratory. The clinical laboratory is accredited by the College of American Pathologists (CAP) and holds licenses in California and several other states.


'/>"/>
SOURCE Biocept, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Norgine B.V. und ... entscheidenden Meilenstein durch diese Veröffentlichung zur  Hepatischen ... um Patientenresultate  bei Verdauungs- und Lebererkrankungen zu ... Verständnis der Hepatischen Enzephalopathie bei und hebt ... Enzephalopathie in der Öffentlichkeit zu schaffen und ...
(Date:5/2/2016)... 2, 2016 Leading Economies with Fastest Real GDP Annual ... 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, , Source: IMF ... , which comprises of Brazil , Russia ... South Africa , registered the fastest GDP growth during the first ... China , recession in Brazil and ...
(Date:5/2/2016)... Mass. , May 2, 2016  While nearly ... that osteoporosis can have on their health, only about ...   according to the results of a new survey ... To mark the start of National Osteoporosis Month, Hologic ... health, which affects nearly 56 million Americans. ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Dr. Poneh Ghasri, ... dental treatments to both new and existing patients. Cosmetic dentistry allows patients to improve ... who have healthy smiles with some minor or more serious cosmetic flaws. These specials ...
(Date:5/3/2016)... ... May 03, 2016 , ... Branches, Inc. is proud to have ... children and youth programs in South Miami. Macy’s is a wonderful community partner and ... Program provides afterschool tutoring, mentoring, enrichment and academic support to elementary students 5 days ...
(Date:5/3/2016)... ... May 03, 2016 , ... Hydra Skin Sciences, a top-rated skincare ... Cream, a revolutionary new anti-aging skin care product that integrates Snow Algae ... has sold over seventy-five thousand units worldwide within the first two months of release. ...
(Date:5/3/2016)... WA (PRWEB) , ... May 03, 2016 , ... Dave ... Pediatric Interim Care Center (PICC) annual fundraiser luncheon on Friday, May 20. ... that helps the smallest victims of drug abuse,” said Newberry. , PICC is a ...
(Date:5/2/2016)... (PRWEB) , ... May 03, 2016 , ... ... of its FDA approved sSOIP telemedicine stethoscope software that enables the stethoscope stream ... is called PCP-SSP and works with RNK’s flagship PCP-USB stethoscope. , Remote auscultation ...
Breaking Medicine News(10 mins):